BioCentury
ARTICLE | Distillery Therapeutics

Therapeutics: Transglutaminase 2 (TGM2; TG2)

August 20, 2015 7:00 AM UTC

In vitro and mouse studies suggest enhancing TGM2 levels could help treat cancer and ophthalmic diseases by inhibiting angiogenesis. In a human umbilical vein endothelial cell line, an shRNA targeting...